SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-20-000151
Filing Date
2020-04-01
Accepted
2020-03-31 17:48:31
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.FOREST BASKETTNEA 14 GP, LTDNEA PARTNERS 14, L.P.PATRICK J. KERINSPETER W. SONSINISCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEA 14 LP / LUMOS PHARMA - SCHEDULE 13D nea14-lumos_18385.htm SC 13D 330933
  Complete submission text file 0001072613-20-000151.txt   332792
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Subject) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86491 | Film No.: 20763045
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 14, L.P. (Filed by) CIK: 0001544328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D